Syngene International Sees Sharp Open Interest Surge Amid Bullish Momentum

Open Interest and Volume Dynamics

On 13 Mar 2026, Syngene International's open interest (OI) surged from 17,108 contracts to 20,631, marking an increase of 3,523 contracts or 20.59%. This rise in OI was accompanied by a robust trading volume of 51,819 contracts, indicating active participation in the derivatives market. The futures segment alone accounted for a value of approximately ₹18,763.65 lakhs, while the options segment's notional value stood at an impressive ₹20,948.48 crores, culminating in a total derivatives value of ₹23,903.24 lakhs for the day.

The underlying stock price closed at ₹423, having touched an intraday high of ₹428, a 5.91% gain, outperforming the healthcare sector's 1-day return of -1.21% and the Sensex's decline of 1.00%. This price action, coupled with the surge in OI, suggests that market participants are positioning for a potential upward move in Syngene International's shares.

Market Positioning and Directional Bets

The sharp increase in open interest alongside rising volumes typically indicates fresh money entering the market rather than short covering. In Syngene's case, the 20.6% OI growth suggests that traders are building new positions, likely bullish given the stock's outperformance and intraday highs. The stock's 1-day return of 4.65% further supports this view, as does the trend reversal after two consecutive days of decline.

However, it is noteworthy that the stock's price remains above its 5-day moving average but below its 20-day, 50-day, 100-day, and 200-day moving averages. This technical setup implies that while short-term momentum is positive, the broader trend remains subdued, warranting cautious optimism among investors.

Investor participation in the cash segment has shown signs of moderation, with delivery volume on 12 Mar falling by 26.8% to 2.3 lakh shares compared to the 5-day average. This decline in delivery volume may indicate that the derivatives market is currently the primary arena for speculative activity rather than long-term accumulation in the cash market.

Mojo Score and Market Capitalisation Context

Despite the positive derivatives activity and price gains, Syngene International carries a Mojo Score of 28.0, categorised as a Strong Sell. This rating was downgraded from Sell on 19 Jan 2026, reflecting concerns over the stock's fundamental and technical outlook. The company is classified as a small-cap with a market capitalisation of ₹17,117 crores, operating within the Healthcare Services sector.

The divergence between the derivatives market enthusiasm and the Mojo Grade suggests that while short-term traders are betting on a rebound, longer-term investors and analysts remain cautious. This could be due to sectoral headwinds, valuation concerns, or company-specific factors not immediately evident in price action.

Liquidity and Trading Considerations

Liquidity remains adequate for Syngene International, with the stock's traded value supporting a trade size of approximately ₹0.54 crore based on 2% of the 5-day average traded value. This level of liquidity facilitates active trading in both cash and derivatives segments, enabling institutional and retail participants to execute sizeable orders without significant market impact.

Given the stock's recent outperformance—gaining 4.21% on the day and outperforming the sector by 5.76%—investors should monitor whether the open interest surge translates into sustained price momentum or if it represents a short-lived speculative spike.

Implications for Investors and Traders

The surge in open interest and volume in Syngene International's derivatives signals a shift in market sentiment, with traders increasingly positioning for a potential upside. This is supported by the stock's intraday high of ₹428 and a 1-day return of 4.65%, outperforming both sector and benchmark indices.

However, the prevailing Strong Sell mojo grade and the stock's position below key longer-term moving averages counsel prudence. Investors should weigh the short-term bullish signals against the broader technical and fundamental backdrop before committing capital.

For traders, the active derivatives market offers opportunities to capitalise on volatility and directional bets, but risk management remains paramount given the stock's mixed signals. Monitoring open interest trends, volume patterns, and price action in the coming sessions will be critical to discerning whether the current momentum can be sustained.

Overall, Syngene International's recent derivatives activity highlights the dynamic interplay between market positioning and underlying fundamentals in shaping stock trajectories within the healthcare services sector.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →